Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A Signature of N6-methyladenosine Regulator-Related Genes Predicts Prognoses and Immune Responses for Head and Neck Squamous Cell Carcinoma

3 Feb 2022

Abstract excerpt

This study aimed to construct a signature of N6-methyladenosine (m6A) regulator-related genes that could be used for the prognosis of head and neck squamous cell carcinoma (HNSCC) and to clarify the molecular and immune characteristics and benefits of immune checkpoint inhibitor (ICI) therapy using the prognostic signature to define the subgroups of HNSCC. This study showed that eighteen m6A regulators were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related molecular mechanisms research
Share to RNA modifications and cancer
Share to Viral-associated cancers and disorders

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35185897
DOI: 10.3389/fimmu.2022.809872

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A Signature of N6-methyladenosine Regulator-Related Genes Predicts Prognoses and Immune Responses for Head and Neck Squamous Cell CarcinomaPMID 35185897Read ↗

The Prognostic Value and Immune Landscapes of a m6A/m5C/m1A-Related LncRNAs Signature in Head and Neck Squamous Cell CarcinomaSemantic proximity Read ↗

The Prognostic Value of m6A-related LncRNAs in Patients with HNSCCSemantic proximity Read ↗

Construction of a m6A RNA Methylation Regulator-related Signature for Prognosis and Immune Response in Lung AdenocarcinomaSemantic proximity Read ↗

Identification of a N6-Methyladenosine (m6A)-Related lncRNA Signature for Predicting the Prognosis and Immune Landscape of Lung Squamous Cell CarcinomaSemantic proximity Read ↗

An Immune-associated lncRNA Signature Predicts the Survival of Patients With Head and Neck Squamous Cell CarcinomaSemantic proximity Read ↗

Identification of m6A/m5C-related lncRNA signature for prediction of prognosis and immunotherapy efficacy in esophageal squamous cell carcinomaSemantic proximity Read ↗

Immune-related genes have prognostic significance in head and neck squamous cell carcinoma.Semantic proximity Read ↗

Characterization of The Prognostic m6A-Related lncRNA Signature For Predicting Immune Responses In Esophageal CancerSemantic proximity Read ↗

A Novel Immune-Related lncRNA Signature predict the Immune Landscape and Prognosis for Head and Neck Squamous Cell CarcinomaSemantic proximity Read ↗

An immune-related seven-lncRNA signature for head and neck squamous cell carcinoma.Semantic proximity Read ↗

Construction of a Prognostic m6A-related lncRNA Signature to Predict Immunotherapy and Chemotherapy Response in Hepatocellular CarcinomaSemantic proximity Read ↗

Identification of m6A methyltransferase-related lncRNA signature for predicting immunotherapy and prognosis in patients with hepatocellular carcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.